63.
171. 2000 Nov;60(5):1207-33. doi: 10.2165/00003495-200060050-00012.
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Jenkins MM, Price K, Pounsford JC et al. Roberts JA, Bradding P, Walls AF et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV198. Morris HG. 58. 2005;65(12):1715-34. doi: 10.2165/00003495-200565120-00012.Lung. Sichletidis L, Daskalopoulou E, Kyriazis G et al. Mitra S, Ugur M, Ugur O et al. Jenne JW, Tashkin DP. New York: Pergamon Press; 1990:84-121.130. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Whelan CJ, Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea pig lung and skin. Available from: (http://www.ginasthma.com). Accessed 2010 Jul 7. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213836.htm251. Cardiotoxicity during treatment of severe childhood asthma.
Salmeterol 50 micro;g twice daily in the treatment of mild-to-moderate asthma in childhood mdash;a comparison of two inhalation devices. Salmeterol inhibits plasma exudation and leukocyte emigration induced by leukotriene β25. Jones PW, Bosh TK. Salmeterol: its place in asthma management. GlaxoSmithKline clinical trial register: salmeterol studies. Bunney R. Bronchodilator treatment in asthma: study too small to detect increase in deaths.
Salmeterol/fluticasone propionate (50/500 mcg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. 134.
150. L ouml;tvall J, Lunde H, Ullman A et al. RC591.I6155 1992.109. Adkins JC, McTavish D. Salmeterol: a review of its pharmacological properties and clinical efficacy in the management of children with asthma. Salmeterol and sustained release theophylline: a comparison in asthmatic patients. Nials AT, Sumner MJ, Johnson M et al. Johnson M, Vardey CJ, Whelan CJ.
183. 99. 91. 57.
28. In: Wilson JD, Foster DW, eds. (S)-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle.
92. Veterans’ Health Administration Department of Veteran Affairs. 122.
Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Eggleston PA. Are β-adrenergic bronchodilators safe? 244. 210. Richard K, Wisniewski M, Anderson W. A comparison of salmeterol and ipratropium in ventolin reversible and non-reversible patients with COPD.
Food and Drug Administration.
A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E5.
232. 82.
Guidelines on the management of asthma.
Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. Duration of protection by inhaled salmeterol in exercise-induced asthma. Pearlman DS, Chervinsky P, LaForce C et al. US Department of Health and Human Services.
Standards for the diagnosis and management of patients with COPD: patient version. doi: 10.2165/00003495-199957060-00010. 96. New York, NY: American Thoracic Society, European Respiratory Society; 2004. 116.
Research Triangle Park, NC.
119. 8th ed.
36.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Mullen ML, Mullen B, Carey M. The association between β-agonist use and death from asthma: a meta-analytic integration of case-control studies. O’Connor BJ, Aikman SL, Barnes PJ. 52. Maconochie JG, Forster JK. Friedel HA, Brogden RN. Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?
A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
242.
Food and Drug Administration. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Regular inhaled salbutamol and airway responsiveness to allergen. Rockville, MD; 2010 Feb 18. Salmeterol, a novel, long-acting β87. 214.
39. London, Eng; British Thoracic Society. 78. 146.
144.
83. Philadelphia: WB Saunders; 1992:621-705.56. 68. Cheung D, Timmers MC, Zwinderman AH.
Available from FDA website. Comparison of the efficacy of salmeterol (SMR) and disodium cromoglycate (DSCG) in the treatment of adult chronic asthmatics.
American Thoracic Society.
95. Salmeterol xinafoate/fluticasone GSK 4 4 Enbrel Etanercept Amgen + Pfizer 6 5 Rituxan Rituximab Roche 7 6 Lantus Insulin glargine Sanofi 14 7 Herceptin Trastuzumab Roche 10 8 Crestor rosuvastatin AZ 8 9 Avastin Roche 9 10 1997 Feb.215. 12. 2013 Dec;191(6):663-8. doi: 10.1007/s00408-013-9503-3.
117.